Results 111 to 120 of about 587 (136)

Carnitine Shuttle and Ferroptosis in Cancer. [PDF]

Antioxidants (Basel)
Kim YA, Lee Y, Kim MS.
europepmc   +1 more source

Role of gut microbiota and trimethylamine <i>N</i>-oxide in preeclampsia: pathophysiological insights and therapeutic opportunities. [PDF]

Ann Med Surg (Lond)
Mubeen M, Shazad A, Aziz M, Poudel S.
europepmc   +1 more source

Possibility of Using NO Modulators for Pharmacocorrection of Endothelial Dysfunction After Prenatal Hypoxia. [PDF]

Pharmaceuticals (Basel)
Belenichev I, Popazova O, Yadlovskyi O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Oksenych V, Kamyshnyi O.   +7 more
europepmc   +1 more source

"Brain doping" substances: prohibited or not in sports? [PDF]

Biol Sport
Pokrywka A, Surała O, Grabowska K, Przybyła M, Granda D, Małecki A, Faiss R, Nowacka-Chmielewska M.   +7 more
europepmc   +1 more source

Revealing the Mechanisms of Alzheimer's, Parkinson's and Huntington's Diseases Through Invertebrate Models. [PDF]

Biology (Basel)
Ding X, Wang P, Zhou L, Li X.
europepmc   +1 more source

Elevated phagocytic capacity directs innate spinal cord repair. [PDF]

Cell Rep
Klatt Shaw D, Saraswathy VM, McAdow AR, Zhou L, Park D, Mote R, Saini A, Douthitt AJ, Stepankova K, Unverzagt B, Geoffroy CG, Johnson AN, Mokalled MH.   +12 more
europepmc   +1 more source

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. [PDF]

Antioxidants (Basel)
Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E, Oksenych V, Kamyshnyi O.   +7 more
europepmc   +1 more source

Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complications. [PDF]

Ren Fail
Lei Y, Xiong G, Lei D, Wu H, Peng X, Chen L, Fang Q, Wu Y, Wu Y, Li X, Li Y.   +10 more
europepmc   +1 more source

Inhibition of systemic mammalian metabolism by carnitine mimics from the gut microbiota

Thümmler K, Basak S, Hulme H, Dritsa C, Foreman R, Naseer H, Salah E, Tumber A, Worboys S, Douce G, Haggarty J, Williams R, Taylor V, Ormsby MJ, Whitfield PD, McCullagh JSO, Salt IP, Burchmore R, Goodwin RJA, Schofield CJ, Wall DM.   +20 more
europepmc   +1 more source

Urinary excretion studies of meldonium after multidose parenteral application

Journal of Pharmaceutical and Biomedical Analysis, 2018
Meldonium is a drug exhibiting cardioprotective and anti-ischemic effects. Due to its potential performance-enhancing benefit in sports, meldonium was added to the World Anti-Doping Agency list of prohibited substances in 2016.
Nenad Dikić, Guro Forsdahl, Biljana Jančić Stojanović   +2 more
exaly   +2 more sources